Rystiggo (rozanolixizumab) has been given the green light by the FDA for both anti-AChR and anti-MuSK antibody-positive gMG based on the results of the MycarinG study, which showed that treatment ...

I am appalled at GMG's support for extending the 2017 tax cuts which added trillions of dollars to our ballooning deficit. The TCJA disproportionately benefited billionaires and corporations and ...

The EMA’s human medicines committee issued a positive opinion on Rystiggo (rozanolixizumab) as an add-on to standard therapy for the treatment of adult gMG patients who are anti-acetylcholine ...